Search research articles
Contact Us
Filters
Showing results (11-20 of 33) with videos related to
Page
of 4
Sort By:
Journal of Biological Regulators and Homeostatic Agents
|
September 30, 2017
Clusterin serum level: how does it affect psoriatic patients?
R Buquicchio, C Foti, F Loconsole, et al.
Journal of Biological Regulators and Homeostatic Agents
|
October 10, 2008
Is there an association between antiphospholipid antibodies and psoriasis?
N Cassano, R Buquicchio, V Ranieri, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia
|
December 9, 2010
Adjuvant role of a new emollient cream in patients with palmar and/or plantar psoriasis: a pilot randomized open-label study
N Cassano, R Mantegazza, S Battaglini, et al.
International Journal of Immunopathology and Pharmacology
|
March 30, 2006
Once-weekly administration of high-dosage Etanercept in patients with plaque psoriasis: results of a pilot experience (power study)
N Cassano, F Loconsole, A Galluccio, et al.
Recenti Progressi in Medicina
|
June 1, 1991
[Evaluation of D-dimer levels in obliterating arteriopathies]
V Petruzzellis, M T Ventura, T Florio, et al.
Journal of Biological Regulators and Homeostatic Agents
|
October 10, 2008
Efalizumab in moderate-to-severe plaque psoriasis: a retrospective case series analysis from clinical practice
N Cassano, V Mastrandrea, R Buquicchio, et al.
International Journal of Immunopathology and Pharmacology
|
September 21, 2007
Re-induction as a possible alternative modality of dose escalation of infliximab: a prospective evaluation in a small series of psoriatic patients
N Cassano, A Puglisi Guerra, C Malara, et al.
Journal of Biological Regulators and Homeostatic Agents
|
September 2, 2011
Anti-tumor necrosis factor treatment in occult hepatitis B virus infection: a retrospective analysis of 62 patients with psoriatic disease
N Cassano, V Mastrandrea, M Principi, et al.
International Journal of Immunopathology and Pharmacology
|
October 6, 2004
Infliximab monotherapy for refractory psoriasis: preliminary results
N Cassano, F Loconsole, A Amoruso, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia
|
March 10, 2015
Biosimilar infliximab: an expert view
A Genazzani, G Altomare, N Balato, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 33) with videos related to
Sort By:
Page
of 4
Journal of Biological Regulators and Homeostatic Agents
|
September 30, 2017
Clusterin serum level: how does it affect psoriatic patients?
R Buquicchio, C Foti, F Loconsole, et al.
Journal of Biological Regulators and Homeostatic Agents
|
October 10, 2008
Is there an association between antiphospholipid antibodies and psoriasis?
N Cassano, R Buquicchio, V Ranieri, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia
|
December 9, 2010
Adjuvant role of a new emollient cream in patients with palmar and/or plantar psoriasis: a pilot randomized open-label study
N Cassano, R Mantegazza, S Battaglini, et al.
International Journal of Immunopathology and Pharmacology
|
March 30, 2006
Once-weekly administration of high-dosage Etanercept in patients with plaque psoriasis: results of a pilot experience (power study)
N Cassano, F Loconsole, A Galluccio, et al.
Recenti Progressi in Medicina
|
June 1, 1991
[Evaluation of D-dimer levels in obliterating arteriopathies]
V Petruzzellis, M T Ventura, T Florio, et al.
Journal of Biological Regulators and Homeostatic Agents
|
October 10, 2008
Efalizumab in moderate-to-severe plaque psoriasis: a retrospective case series analysis from clinical practice
N Cassano, V Mastrandrea, R Buquicchio, et al.
International Journal of Immunopathology and Pharmacology
|
September 21, 2007
Re-induction as a possible alternative modality of dose escalation of infliximab: a prospective evaluation in a small series of psoriatic patients
N Cassano, A Puglisi Guerra, C Malara, et al.
Journal of Biological Regulators and Homeostatic Agents
|
September 2, 2011
Anti-tumor necrosis factor treatment in occult hepatitis B virus infection: a retrospective analysis of 62 patients with psoriatic disease
N Cassano, V Mastrandrea, M Principi, et al.
International Journal of Immunopathology and Pharmacology
|
October 6, 2004
Infliximab monotherapy for refractory psoriasis: preliminary results
N Cassano, F Loconsole, A Amoruso, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia
|
March 10, 2015
Biosimilar infliximab: an expert view
A Genazzani, G Altomare, N Balato, et al.
Page
of 4